Skip to content
sellModerate

Mats Wahlstrom sold $74k of CHRS

director at Coherus Oncology, Inc.. 99,988 shares at an average of $0.74, traded May 23, 2025, filed May 28, 2025.

Warning score
43
Value
$74k
99,988 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $74k at market
    +8
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001610717-25-000145, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 23, 2025SOpen-market sale
Common Stockindirect: Leonard Capital, LLC
-99,988$0.74$74k0May 28, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mats Wahlstrom sold $74k of CHRS | InsiderTell